Key facts
- This page summarizes Jack W. Callicutt's Form 4 filing for GALECTIN THERAPEUTICS INC (GALT).
- 15 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 19 Nov 2025, 16:01.
Jack W. Callicutt - 17 Nov 2025 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- GALT
- Reported as of
- 17 Nov 2025
- Net transaction value
- -$359,292
- SEC form
- 4
- Accepted by SEC
- 19 Nov 2025, 16:01:12 UTC
- Prior SEC filing
- 12 Nov 2025
- Next SEC filing
- 06 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- Jack W. Callicutt
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jack W. Callicutt filed Form 4 for GALECTIN THERAPEUTICS INC (GALT) on 19 Nov 2025.
Change
- Previous filing in this sequence was filed on 12 Nov 2025.
- Current net transaction value: -$359,292.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001266773
Primary reporting owner
CALLICUTT JACK W
- Relationship
- Chief Financial Officer
- Address
- C/O GALECTIN THERAPEUTICS INC., 4960 PEACHTREE INDUSTRIAL BLVD., STE 240, NORCROSS
- Signature
- Jack W. Callicutt
- Signature date
- 19 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GALT
transaction
Common stock
Options Exercise
- Transaction value
- $18,980
- Shares
- +9,586
- Change %
- +126%
- Price
- $1.98
- Shares after
- 17,200
- Date
- 17 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
GALT
transaction
Common stock
Sale
- Transaction value
- $57,820
- Shares
- -9,586
- Change %
- -56%
- Price
- $6.03
- Shares after
- 7,614
- Date
- 17 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F5
GALT
transaction
Common stock
Options Exercise
- Transaction value
- $21,868
- Shares
- +19,701
- Change %
- +259%
- Price
- $1.11
- Shares after
- 27,315
- Date
- 17 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
GALT
transaction
Common stock
Sale
- Transaction value
- $118,831
- Shares
- -19,701
- Change %
- -72%
- Price
- $6.03
- Shares after
- 7,614
- Date
- 17 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F5
GALT
transaction
Common stock
Options Exercise
- Transaction value
- $2,857
- Shares
- +2,323
- Change %
- +31%
- Price
- $1.23
- Shares after
- 9,937
- Date
- 17 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
GALT
transaction
Common stock
Sale
- Transaction value
- $14,012
- Shares
- -2,323
- Change %
- -23%
- Price
- $6.03
- Shares after
- 7,614
- Date
- 17 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F5
GALT
transaction
Common stock
Options Exercise
- Transaction value
- $55,638
- Shares
- +28,100
- Change %
- +369%
- Price
- $1.98
- Shares after
- 35,714
- Date
- 18 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
GALT
transaction
Common stock
Sale
- Transaction value
- $174,866
- Shares
- -28,100
- Change %
- -79%
- Price
- $6.22
- Shares after
- 7,614
- Date
- 18 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F6
GALT
transaction
Common stock
Options Exercise
- Transaction value
- $20,213
- Shares
- +18,210
- Change %
- +239%
- Price
- $1.11
- Shares after
- 25,824
- Date
- 18 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
GALT
transaction
Common stock
Sale
- Transaction value
- $113,321
- Shares
- -18,210
- Change %
- -71%
- Price
- $6.22
- Shares after
- 7,614
- Date
- 18 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F6
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GALT
transaction
Derivative
Stock option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -9,586
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 28,120
- Date
- 17 Nov 2025
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 9,586
- Exercise price
- $1.98
- Footnotes
- F1, F2
GALT
transaction
Derivative
Stock option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -19,701
- Change %
- -52%
- Price
- $0.000000
- Shares after
- 18,190
- Date
- 17 Nov 2025
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 19,701
- Exercise price
- $1.11
- Footnotes
- F1, F3
GALT
transaction
Derivative
Stock option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,323
- Change %
- -4.5%
- Price
- $0.000000
- Shares after
- 48,750
- Date
- 17 Nov 2025
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 2,323
- Exercise price
- $1.23
- Footnotes
- F1, F4
GALT
transaction
Derivative
Stock option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -28,120
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 28,120
- Exercise price
- $1.98
- Footnotes
- F1, F2
GALT
transaction
Derivative
Common stock (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -18,190
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 18,190
- Exercise price
- $1.11
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 6 footnotes
Footnote F1
The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025.
Footnote F2
The options vested as follows: 25% on each of June 30, 2022, December 31, 2022, June 30, 2023, and December 31, 2023.
Footnote F3
The options vested as follows: 25% on each of June 30, 2023, December 31, 2023, June 30, 2024, and December 31, 2024.
Footnote F4
The options vests as follows: 25% on June 30, 2025, with 25% scheduled to vest on each of December 31, 2025, June 30, 2026, on December 31, 2026.
Footnote F5
The shares were sold in multiple transactions at prices ranging from $6.00 to $6.10. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Footnote F6
The shares were sold in multiple transactions at prices ranging from $6.00 to $6.30. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.